1.
Low Prevalence of High-dose Methotrexate Nephropathy in Patients With Malignancy. IJKD [Internet]. 2012 Mar. 2 [cited 2024 May 21];6(2):105-9. Available from: https://www.ijkd.org/index.php/ijkd/article/view/643